Skip to content
Advertisement

This April 9, 2012 photo provided by Virginia Commonwealth University Relations shows Dr. Frank Gupton, PhD., co-founder of Phlow, chair of Virginia Commonwealth University's Department of Chemical and Life Science Engineering and CEO of the Medicines for All Institute, in Richmond, Va. The Department of Health and Human Services announced Tuesday, May 19, 2020, it was awarding a contract worth up to $812 million to Richmond-based Phlow to manufacture pharmaceutical ingredients, chemical compounds and generic drugs inside the United States. (Thomas Kojcsich/Virginia Commonwealth University School of Engineering)

This April 9, 2012 photo provided by Virginia Commonwealth University Relations shows Dr. Frank Gupton, PhD., co-founder of Phlow, chair of Virginia Commonwealth University's Department of Chemical and Life Science Engineering and CEO of the Medicines for All Institute, in Richmond, Va. The Department of Health and Human Services announced Tuesday, May 19, 2020, it was awarding a contract worth up to $812 million to Richmond-based Phlow to manufacture pharmaceutical ingredients, chemical compounds and generic drugs inside the United States. (Thomas Kojcsich/Virginia Commonwealth University School of Engineering)

Featured Photo Galleries